Exact Mass: 674.2504624

Exact Mass Matches: 674.2504624

Found 154 metabolites which its exact mass value is equals to given mass value 674.2504624, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

(N-acetylneuraminosyl(a2-6)lactosamine)

(2R,4S,5R,6R)-5-Acetamido-2-{[(2R,3R,4S,5R,6S)-6-{[(2R,3S,4R,5R,6R)-5-acetamido-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methoxy}-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid

C25H42N2O19 (674.2381662)


(N-acetylneuraminosyl(alpha2-6)lactosamine) is widely distributed among tissues and is involved in biological processes such as the regulation of the immune response and the progression of colon cancer. Sialylation represents one of the most frequently occurring terminations of the oligosaccharide chains of glycoproteins and glycolipids. Sialic acid is commonly found alpha,6-linked to N-acetylgalactosamine (GalNAc). The biosynthesis of the linkage is mediated by a member of the sialyltransferase family, the beta-galactoside alpha,6-sialyltransferase (EC 2.4.99.1, ST6Gal.I). Although expressed by a single gene, this enzyme shows a complex pattern of regulation which allows its tissue- and stage-specific modulation. (PMID 11425186)

.

6-Sialyllactosamine is an oligosaccharide found in human milk. Oligosaccharides in human milk inhibit enteric pathogens in vitro and in vivo. (PMID:10683228)

.

(N-acetylneuraminosyl(alpha2-6)lactosamine) is widely distributed among tissues and is involved in biological processes such as the regulation of the immune response and the progression of colon cancer. Sialylation represents one of the most frequently occurring terminations of the oligosaccharide chains of glycoproteins and glycolipids. Sialic acid is commonly found alpha,6-linked to N-acetylgalactosamine (GalNAc). The biosynthesis of the linkage is mediated by a member of the sialyltransferase family, the beta-galactoside alpha,6-sialyltransferase (EC 2.4.99.1, ST6Gal.I). Although expressed by a single gene, this enzyme shows a complex pattern of regulation which allows its tissue- and stage-specific modulation. (PMID 11425186)

   
   

Premithramycin A2

Premithramycin A2

C33H38O15 (674.2210598)


A tetracenomycin that is an intermediate in the biosynthesis of the antitumour drug mithramycin by Streptomyces argillaceus.

   

3-Sialyl-N-acetyllactosamine

(2R,4S,5R,6R)-2-{[(2S,3R,4S,5S,6R)-2-{[(2R,3S,4R,5R)-4,5-dihydroxy-6-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-5-[(1-hydroxyethylidene)amino]-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylate

C25H42N2O19 (674.2381662)


3-Sialyl-N-acetyllactosamine is a normal sialyloligosaccharide that is present in human biofluids, and is one of the predominant oligosaccharides in human urine as a free form. The presence of these compounds in the urine is linked to the biosynthesis and degradation of the body glycoproteins, glycolipids, and glycans. Under certain pathological conditions, the total urinary carbohydrate-material is increased dramatically, and the number and ratios of the components present are also increased. Many of these pathological disorders are the result of a deficiency in a specific exoglycosidase. 3-Sialyl-N-acetyllactosamine have a sialyl(a2-3) linkage and is of interest in view of the discovery of uropathogenic Escherichia coli strains with binding specificity for sialyl(a2-3)galactosides. (PMID: 2445744; 2775488; 3813552; 6619126; 6628386; 6628680; 6714239; 6746638; 7925342) [HMDB] 3-Sialyl-N-acetyllactosamine is a normal sialyloligosaccharide that is present in human biofluids, and is one of the predominant oligosaccharides in human urine as a free form. The presence of these compounds in the urine is linked to the biosynthesis and degradation of the body glycoproteins, glycolipids, and glycans. Under certain pathological conditions, the total urinary carbohydrate-material is increased dramatically, and the number and ratios of the components present are also increased. Many of these pathological disorders are the result of a deficiency in a specific exoglycosidase. 3-Sialyl-N-acetyllactosamine have a sialyl(a2-3) linkage and is of interest in view of the discovery of uropathogenic Escherichia coli strains with binding specificity for sialyl(a2-3)galactosides. (PMID: 2445744; 2775488; 3813552; 6619126; 6628386; 6628680; 6714239; 6746638; 7925342).

   

6-Sialyl-N-acetyllactosamine

(2S,4S,5R,6R)-2-{[(2R,3R,4S,5R,6S)-6-{[(2R,3S,4R,5R)-4,6-dihydroxy-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)oxan-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methoxy}-4-hydroxy-5-[(1-hydroxyethylidene)amino]-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylate

C25H42N2O19 (674.2381662)


6-Sialyl-N-acetyllactosamine is an oligosaccharide widely distributed among tissues and is involved in biological processes such as the regulation of the immune response and the progression of colon cancer. Sialylation represents one of the most frequently occurring terminations of the oligosaccharide chains of glycoproteins and glycolipids. Sialic acid is commonly found alpha,3- or alpha,6-linked to galactose (Gal), alpha,6-linked to N-acetylgalactosamine (GalNAc) or alpha,8-linked to another sialic acid. The biosynthesis of the various linkages is mediated by the different members of the sialyltransferase family. The b-galactoside a2,6 sialyltransferase (EC 2.4.99.1, ST6Gal.I) is the only sialyltransferase so far identified able to catalyze the a2,6-sialylation of lactosamine. Although expressed by a single gene, this enzyme shows a complex pattern of regulation which allows its tissue- and stage-specific modulation. The level of expression of the sialyl-alpha2,6-lactosaminyl structures and of ST6Gal.I show a strong dependence on neoplastic transformation and differentiation in several tissues. (PMID: 11425186) [HMDB] 6-Sialyl-N-acetyllactosamine is an oligosaccharide widely distributed among tissues and is involved in biological processes such as the regulation of the immune response and the progression of colon cancer. Sialylation represents one of the most frequently occurring terminations of the oligosaccharide chains of glycoproteins and glycolipids. Sialic acid is commonly found alpha,3- or alpha,6-linked to galactose (Gal), alpha,6-linked to N-acetylgalactosamine (GalNAc) or alpha,8-linked to another sialic acid. The biosynthesis of the various linkages is mediated by the different members of the sialyltransferase family. The b-galactoside a2,6 sialyltransferase (EC 2.4.99.1, ST6Gal.I) is the only sialyltransferase so far identified able to catalyze the a2,6-sialylation of lactosamine. Although expressed by a single gene, this enzyme shows a complex pattern of regulation which allows its tissue- and stage-specific modulation. The level of expression of the sialyl-alpha2,6-lactosaminyl structures and of ST6Gal.I show a strong dependence on neoplastic transformation and differentiation in several tissues. (PMID: 11425186).

   

3'-Sialyl-N-acetyllactosamine

2-{[2-({4,6-dihydroxy-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)oxan-3-yl}oxy)-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-5-[(1-hydroxyethylidene)amino]-6-(1,2,3-trihydroxypropyl)oxane-2-carboxylate

C25H42N2O19 (674.2381662)


   

Dirlotapide

N-{2-[Benzyl(methyl)amino]-2-oxo-1-phenylethyl}-1-methyl-5-{[4-(trifluoromethyl)[1,1-biphenyl]-2-carbonyl]amino}-1H-indole-2-carboxamide

C40H33F3N4O3 (674.2504624)


   
   
   
   
   
   
   

Dulcisbiflavonoid A

Dulcisbiflavonoid A

C40H34O10 (674.2151864)


   

Mucusisoflavone C

Mucusisoflavone C

C40H34O10 (674.2151864)


A hydroxyisoflavone, isoflavone dimer obtained from Ficus mucuso.

   
   

3-b-Sialyl-N-acetyllactosamine

3-b-Sialyl-N-acetyllactosamine

C25H42N2O19 (674.2381662)


   

Halistanol sulfate G

(2beta,3alpha,5alpha,6alpha)-ergostane-2,3,6-triyl tris(hydrogen sulfate)

C28H50O12S3 (674.246426)


   
   
   

(+)-dihydrodehydrodiconiferyl alcohol 4-O-beta-(6-O-galloyl)-glucopyranoside

(+)-dihydrodehydrodiconiferyl alcohol 4-O-beta-(6-O-galloyl)-glucopyranoside

C33H38O15 (674.2210598)


   
   

Boc-Gly-Pro-Hyp-Gly-Ala-Gly-OBzl-Antiarrhythmic peptide(ox atrium)

Boc-Gly-Pro-Hyp-Gly-Ala-Gly-OBzl-Antiarrhythmic peptide(ox atrium)

C31H42N6O11 (674.2911422)


   
   
   

neoorthosiphonone A

neoorthosiphonone A

C38H42O11 (674.2726982)


   
   
   

(-)-(7S,8R,8R)-9-O-galloyllariciresinol-4-O-beta-D-glucopyranoside|balaxiflorin A

(-)-(7S,8R,8R)-9-O-galloyllariciresinol-4-O-beta-D-glucopyranoside|balaxiflorin A

C33H38O15 (674.2210598)


   
   
   
   
   
   
   
   
   

(4alpha,5beta,10alpha,14alpha)-14,19-dihydroxyabieta-8,13(15)-dieno-16,12-lactone 19-(2-O-(4-hydroxy-3,5-dimethoxybenzoyl)-beta-D-glucopyranoside)|curvifloruside B|rel-(4R,4aS,7R,10aR,11bR)-2,3,4,4a,5,6,7,10a,11,11b-decahydro-7-hydroxy-4-({[2-O-(4-hydroxy-3,4-dimethoxybenzoyl)-beta-D-glucopyranosyl]oxy}methyl)-4,8,11b-trimethylphenanthro[3,2-b]furan-9(1H)-one

(4alpha,5beta,10alpha,14alpha)-14,19-dihydroxyabieta-8,13(15)-dieno-16,12-lactone 19-(2-O-(4-hydroxy-3,5-dimethoxybenzoyl)-beta-D-glucopyranoside)|curvifloruside B|rel-(4R,4aS,7R,10aR,11bR)-2,3,4,4a,5,6,7,10a,11,11b-decahydro-7-hydroxy-4-({[2-O-(4-hydroxy-3,4-dimethoxybenzoyl)-beta-D-glucopyranosyl]oxy}methyl)-4,8,11b-trimethylphenanthro[3,2-b]furan-9(1H)-one

C35H46O13 (674.2938266)


   
   

6alpha,12-diacetoxy-2beta,9alpha-di(beta-furancarbonyloxy)-4alpha-hydroxy-1beta-(2-methylbutanoyloxy)-beta-dihydroagarofuran

6alpha,12-diacetoxy-2beta,9alpha-di(beta-furancarbonyloxy)-4alpha-hydroxy-1beta-(2-methylbutanoyloxy)-beta-dihydroagarofuran

C34H42O14 (674.2574432)


   

(-)-secoisolariciresinol 4-O-beta-D-(6-O-vanilloyl)glucopyranoside|glehlinoside A

(-)-secoisolariciresinol 4-O-beta-D-(6-O-vanilloyl)glucopyranoside|glehlinoside A

C34H42O14 (674.2574432)


   
   
   

C34H42O14_(1S,2S,4S,5R,6R,7S,9R,12R)-12-Acetoxy-6-(acetoxymethyl)-2-hydroxy-2,10,10-trimethyl-5-[(2-methylbutanoyl)oxy]-11-oxatricyclo[7.2.1.0~1,6~]dodecane-4,7-diyl di(3-furoate)

NCGC00384622-01_C34H42O14_(1S,2S,4S,5R,6R,7S,9R,12R)-12-Acetoxy-6-(acetoxymethyl)-2-hydroxy-2,10,10-trimethyl-5-[(2-methylbutanoyl)oxy]-11-oxatricyclo[7.2.1.0~1,6~]dodecane-4,7-diyl di(3-furoate)

C34H42O14 (674.2574432)


   

Biflavonoid-flavone base + 3MeO and flavone base + 3MeO

Biflavonoid-flavone base + 3MeO and flavone base + 3MeO

C40H34O10 (674.2151864)


Annotation level-3

   

Phe His Trp Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C37H38N8O5 (674.2965018)


   

Phe Trp His Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C37H38N8O5 (674.2965018)


   

Phe Trp Trp His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C37H38N8O5 (674.2965018)


   

His Phe Trp Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C37H38N8O5 (674.2965018)


   

His Trp Phe Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C37H38N8O5 (674.2965018)


   

His Trp Trp Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

C37H38N8O5 (674.2965018)


   

Trp Phe His Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C37H38N8O5 (674.2965018)


   

Trp Phe Trp His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C37H38N8O5 (674.2965018)


   

Trp His Phe Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C37H38N8O5 (674.2965018)


   

Trp His Trp Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

C37H38N8O5 (674.2965018)


   

Trp Trp Phe His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C37H38N8O5 (674.2965018)


   

Trp Trp His Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanoic acid

C37H38N8O5 (674.2965018)


   

3-SLN

5-acetamido-2-[2-(5-acetamido-1,2,4-trihydroxy-6-oxohexan-3-yl)oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-(1,2,3-trihydroxypropyl)oxane-2-carboxylic acid

C25H42N2O19 (674.2381662)


   

NeuAc alpha,6gal beta1,4gicnac

O-(N-Acetyl-alpha-neuraminosyl)-(2->6)-O-beta-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-D-glucose

C25H42N2O19 (674.2381662)


   

5,10,15,20-TETRAKIS(4-AMINOPHENYL)-21H,23H-PORPHINE

5,10,15,20-TETRAKIS(4-AMINOPHENYL)-21H,23H-PORPHINE

C44H34N8 (674.2906284)


   

[1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene](1,3-diphenyl-1,3-propanedionato)copper(I)

[1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene](1,3-diphenyl-1,3-propanedionato)copper(I)

C42H47CuN2O2 (674.2933332000001)


   
   

O-(N-Acetyl-alpha-neuraminosyl)-(2-6)-O-beta-D-galactopyranosyl-(1-4)-2-(acetylamino)-2-deoxy-D-galactose

O-(N-Acetyl-alpha-neuraminosyl)-(2-6)-O-beta-D-galactopyranosyl-(1-4)-2-(acetylamino)-2-deoxy-D-galactose

C25H42N2O19 (674.2381662)


   

Dirlotapide

Dirlotapide

C40H33F3N4O3 (674.2504624)


C78272 - Agent Affecting Nervous System > C29728 - Anorexiant

   
   

Neu5Acalpha2-3Galbeta1-3GlcNAcbeta

Neu5Acalpha2-3Galbeta1-3GlcNAcbeta

C25H42N2O19 (674.2381662)


   

Tetrakis(o-aminophenyl)porphyrin

Tetrakis(o-aminophenyl)porphyrin

C44H34N8 (674.2906284)


   

1-[(2R,3R)-2-[[2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(1-naphthalenyl)urea

1-[(2R,3R)-2-[[2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(1-naphthalenyl)urea

C35H38N4O8S (674.2410228000001)


   

NeuAc(a2-6)Gal(b1-4)GlcNAc

NeuAc(a2-6)Gal(b1-4)GlcNAc

C25H42N2O19 (674.2381662)


   

beta-D-galactosyl-(1->3)-[alpha-N-acetylneuraminosyl-(2->6)]-N-acetyl-alpha-D-galactosamine

beta-D-galactosyl-(1->3)-[alpha-N-acetylneuraminosyl-(2->6)]-N-acetyl-alpha-D-galactosamine

C25H42N2O19 (674.2381662)


   

alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

C25H42N2O19 (674.2381662)


   

alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)-alpha-D-GalpNAc

alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)-alpha-D-GalpNAc

C25H42N2O19 (674.2381662)


   

3-alpha-Sialyl-N-acetyllactosamine

3-alpha-Sialyl-N-acetyllactosamine

C25H42N2O19 (674.2381662)


   

beta-NeupNAc-(2->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

beta-NeupNAc-(2->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

C25H42N2O19 (674.2381662)


   

Gal(b1-3)[NeuAc(a2-6)]a-GlcNAc

Gal(b1-3)[NeuAc(a2-6)]a-GlcNAc

C25H42N2O19 (674.2381662)


   

2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)-[5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)]-beta-D-galactopyranose

2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)-[5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)]-beta-D-galactopyranose

C25H42N2O19 (674.2381662)


   

Gal(b1-3)[NeuAc(a2-6)]b-GlcNAc

Gal(b1-3)[NeuAc(a2-6)]b-GlcNAc

C25H42N2O19 (674.2381662)


   

Gal(b1-3)[NeuAc(a2-6)]b-GalNAc

Gal(b1-3)[NeuAc(a2-6)]b-GalNAc

C25H42N2O19 (674.2381662)


   

locoracemoside C

locoracemoside C

C29H38O18 (674.2058048)


An O-acyl carbohydrate consisting of 6-O-beta-D-glucopyranosyl-beta-D-glucopyranose attached to a 3,4,5-trimethoxybenzyl and a galloyl group at positions 1 and 3 respectively. Isolated from Symplocos racemosa, it exhibits inhibitory activity against chymotrypsin.

   

NeuAc(a2-6)Man(b1-4)GlcNAc

NeuAc(a2-6)Man(b1-4)GlcNAc

C25H42N2O19 (674.2381662)


   

alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)-D-GalpNAc

alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)-D-GalpNAc

C25H42N2O19 (674.2381662)


   

Gal(b1-3)[NeuAc(a2-6)]GalNAc

Gal(b1-3)[NeuAc(a2-6)]GalNAc

C25H42N2O19 (674.2381662)


   

alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-D-GlcpNAc

alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-D-GlcpNAc

C25H42N2O19 (674.2381662)


   

beta-D-Galp-(1->3)-[beta-Neup5Ac-(2->6)]-alpha-D-GalpNAc

beta-D-Galp-(1->3)-[beta-Neup5Ac-(2->6)]-alpha-D-GalpNAc

C25H42N2O19 (674.2381662)


   

Gal(a1-3)[NeuAc(a2-6)]a-GalNAc

Gal(a1-3)[NeuAc(a2-6)]a-GalNAc

C25H42N2O19 (674.2381662)


   

2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)-[5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)]-D-galactopyranose

2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)-[5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)]-D-galactopyranose

C25H42N2O19 (674.2381662)


   

NeuAc(a2-6)Gal(b1-4)a-GlcNAc

NeuAc(a2-6)Gal(b1-4)a-GlcNAc

C25H42N2O19 (674.2381662)


   

NeuAc(a2-6)Gal(b1-3)a-GalNAc

NeuAc(a2-6)Gal(b1-3)a-GalNAc

C25H42N2O19 (674.2381662)


   

NeuAc(a2-3)Gal(b1-4)a-GlcNAc

NeuAc(a2-3)Gal(b1-4)a-GlcNAc

C25H42N2O19 (674.2381662)


   

NeuAc(a2-6)Gal(b1-3)GalNAc

NeuAc(a2-6)Gal(b1-3)GalNAc

C25H42N2O19 (674.2381662)


   

Gal(a1-3)[NeuAc(a2-6)]GalNAc

Gal(a1-3)[NeuAc(a2-6)]GalNAc

C25H42N2O19 (674.2381662)


   

3-a-Sialyl-N-acetyllactosamine

3-a-Sialyl-N-acetyllactosamine

C25H42N2O19 (674.2381662)


   

NeuAc(a2-6)Gal(a1-3)a-GalNAc

NeuAc(a2-6)Gal(a1-3)a-GalNAc

C25H42N2O19 (674.2381662)


   

NeuAc(a2-6)Gal(b1-3)b-GalNAc

NeuAc(a2-6)Gal(b1-3)b-GalNAc

C25H42N2O19 (674.2381662)


   

Gal(b1-4)[NeuAc(a2-6)]GalNAc

Gal(b1-4)[NeuAc(a2-6)]GalNAc

C25H42N2O19 (674.2381662)


   

NeuAc(a2-6)Gal(b1-3)GlcNAc

NeuAc(a2-6)Gal(b1-3)GlcNAc

C25H42N2O19 (674.2381662)


   

NeuAc(b2-3)Gal(b1-3)a-GalNAc

NeuAc(b2-3)Gal(b1-3)a-GalNAc

C25H42N2O19 (674.2381662)


   

NeuAc(b2-6)GalNAc(b1-4)Glc

NeuAc(b2-6)GalNAc(b1-4)Glc

C25H42N2O19 (674.2381662)


   

NeuAc(a2-6)GalNAc(b1-4)Glc

NeuAc(a2-6)GalNAc(b1-4)Glc

C25H42N2O19 (674.2381662)


   

Gal(b1-3)[NeuAc(a2-6)]GlcNAc

Gal(b1-3)[NeuAc(a2-6)]GlcNAc

C25H42N2O19 (674.2381662)


   

NeuAc(a2-6)Gal(b1-4)HexNAc

NeuAc(a2-6)Gal(b1-4)HexNAc

C25H42N2O19 (674.2381662)


   

5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid-(2->3)-D-galacto-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-alpha-D-galacto-hexopyranose

5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid-(2->3)-D-galacto-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-alpha-D-galacto-hexopyranose

C25H42N2O19 (674.2381662)


   

D-galacto-hexopyranosyl-(1->3)-[5-acetamido-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->6)]-2-acetamido-2-deoxy-alpha-D-galacto-hexopyranose

D-galacto-hexopyranosyl-(1->3)-[5-acetamido-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->6)]-2-acetamido-2-deoxy-alpha-D-galacto-hexopyranose

C25H42N2O19 (674.2381662)


   

Neu5Acalpha2-6GlcNAcbeta1-3Galbeta

Neu5Acalpha2-6GlcNAcbeta1-3Galbeta

C25H42N2O19 (674.2381662)


   

NeuAc(a2-3)Gal(a1-3)b-GlcNAc

NeuAc(a2-3)Gal(a1-3)b-GlcNAc

C25H42N2O19 (674.2381662)


   

NeuAc(a2-3)Gal(a1-4)b-GlcNAc

NeuAc(a2-3)Gal(a1-4)b-GlcNAc

C25H42N2O19 (674.2381662)


   

[(1S,4R,6E,9R,12R,13S,15R,16R)-4,9-dibenzyl-15-(hydroxymethyl)-13-methoxy-3,10-dioxo-2,11,14-trioxabicyclo[10.4.0]hexadec-6-en-16-yl] 2,6-dimethoxybenzoate

[(1S,4R,6E,9R,12R,13S,15R,16R)-4,9-dibenzyl-15-(hydroxymethyl)-13-methoxy-3,10-dioxo-2,11,14-trioxabicyclo[10.4.0]hexadec-6-en-16-yl] 2,6-dimethoxybenzoate

C38H42O11 (674.2726982)


   

NeuAc(a2-6)Glc(b1-4)b-GlcNAc

NeuAc(a2-6)Glc(b1-4)b-GlcNAc

C25H42N2O19 (674.2381662)


   

NeuAc(a2-6)Glc(b1-4)GlcNAc

NeuAc(a2-6)Glc(b1-4)GlcNAc

C25H42N2O19 (674.2381662)


   

NeuAc(a2-6)Gal(b1-3)b-GlcNAc

NeuAc(a2-6)Gal(b1-3)b-GlcNAc

C25H42N2O19 (674.2381662)


   

NeuAc(b2-6)Gal(b1-4)a-GlcNAc

NeuAc(b2-6)Gal(b1-4)a-GlcNAc

C25H42N2O19 (674.2381662)


   

NeuAc(a2-3)GalNAc(b1-3)Gal

NeuAc(a2-3)GalNAc(b1-3)Gal

C25H42N2O19 (674.2381662)


   

5-acetamido-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->3)-beta-D-galacto-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-D-galacto-hexopyranose

5-acetamido-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->3)-beta-D-galacto-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-D-galacto-hexopyranose

C25H42N2O19 (674.2381662)


   

3-O-[3-O-[(N-Acetyl-2-deoxy-alpha-neuraminic acid)-2-yl]-D-galactopyranosyl]-2-(acetylamino)-2-deoxy-D-galactopyranose

3-O-[3-O-[(N-Acetyl-2-deoxy-alpha-neuraminic acid)-2-yl]-D-galactopyranosyl]-2-(acetylamino)-2-deoxy-D-galactopyranose

C25H42N2O19 (674.2381662)


   

NeuAc(a2-3)Gal(b1-4)GalNAc

NeuAc(a2-3)Gal(b1-4)GalNAc

C25H42N2O19 (674.2381662)


   

NeuAc(a2-6)Gal(a1-3)GalNAc

NeuAc(a2-6)Gal(a1-3)GalNAc

C25H42N2O19 (674.2381662)


   

NeuAc(a2-6)Man(b1-4)b-GlcNAc

NeuAc(a2-6)Man(b1-4)b-GlcNAc

C25H42N2O19 (674.2381662)


   

NeuAc(b2-3)Gal(b1-3)GalNAc

NeuAc(b2-3)Gal(b1-3)GalNAc

C25H42N2O19 (674.2381662)


   

D-galacto-hexopyranosyl-(1->3)-[5-acetamido-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->6)]-2-acetamido-2-deoxy-D-galacto-hexopyranose

D-galacto-hexopyranosyl-(1->3)-[5-acetamido-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->6)]-2-acetamido-2-deoxy-D-galacto-hexopyranose

C25H42N2O19 (674.2381662)


   

NeuAc(a2-3)Gal(b1-3)GlcNAc

NeuAc(a2-3)Gal(b1-3)GlcNAc

C25H42N2O19 (674.2381662)


   

NeuAc(a2-3)GalNAc(b1-4)Glc

NeuAc(a2-3)GalNAc(b1-4)Glc

C25H42N2O19 (674.2381662)


   

NeuAc(a2-3)Gal(b1-3)a-GlcNAc

NeuAc(a2-3)Gal(b1-3)a-GlcNAc

C25H42N2O19 (674.2381662)


   

5-acetamido-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->3)-beta-D-galacto-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-alpha-D-galacto-hexopyranose

5-acetamido-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->3)-beta-D-galacto-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-alpha-D-galacto-hexopyranose

C25H42N2O19 (674.2381662)


   

Gal(b1-3)[NeuAc(b2-6)]b-GalNAc

Gal(b1-3)[NeuAc(b2-6)]b-GalNAc

C25H42N2O19 (674.2381662)


   

5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid-(2->3)-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-hexopyranose

5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid-(2->3)-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-hexopyranose

C25H42N2O19 (674.2381662)


   

Neu5Acalpha2-6GlcNAcbeta1-3Glcbeta

Neu5Acalpha2-6GlcNAcbeta1-3Glcbeta

C25H42N2O19 (674.2381662)


   

Ferrioxamine G1 [M+Fe-2H]

Ferrioxamine G1 [M+Fe-2H]

C27H50FeN6O10 (674.293763)


   
   
   

3-Sialyl-N-acetyllactosamine

3-Sialyl-N-acetyllactosamine

C25H42N2O19 (674.2381662)


   

6-Sialyl-N-acetyllactosamine

6-Sialyl-N-acetyllactosamine

C25H42N2O19 (674.2381662)


   

(2beta,3alpha,5alpha,6alpha)-ergostane-2,3,6-triyl tris(hydrogen sulfate)

(2beta,3alpha,5alpha,6alpha)-ergostane-2,3,6-triyl tris(hydrogen sulfate)

C28H50O12S3 (674.246426)


   

Halistanol sulfonic acid G

Halistanol sulfonic acid G

C28H50O12S3 (674.246426)


A steroid sulfate that is 5alpha-ergostane substituted by sulfate groups at positions 2, 3 and 6 (the (2beta,3alpha,6alpha stereoisomer).

   
   
   
   
   

(7r)-7-[(1z)-2-(1,5-dihydroxy-3-methoxy-10-methyl-9-oxoacridin-4-yl)ethenyl]-15-hydroxy-2,7,19,19-tetramethyl-5,8,18-trioxa-2-azapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁷,²²]docosa-1(22),3,9,11,14,16,20-heptaen-13-one

(7r)-7-[(1z)-2-(1,5-dihydroxy-3-methoxy-10-methyl-9-oxoacridin-4-yl)ethenyl]-15-hydroxy-2,7,19,19-tetramethyl-5,8,18-trioxa-2-azapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁷,²²]docosa-1(22),3,9,11,14,16,20-heptaen-13-one

C39H34N2O9 (674.2264194)


   

(2s,4s,5r,6r)-6-[(1r,2r)-2,3-dihydroxy-1-{[(2s,3r,4r,5s,6r)-5-hydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}propyl]-2,4-dihydroxy-5-[(1-hydroxyethylidene)amino]oxane-2-carboxylic acid

(2s,4s,5r,6r)-6-[(1r,2r)-2,3-dihydroxy-1-{[(2s,3r,4r,5s,6r)-5-hydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}propyl]-2,4-dihydroxy-5-[(1-hydroxyethylidene)amino]oxane-2-carboxylic acid

C25H42N2O19 (674.2381662)


   

4,4',5,5'-tetrahydroxy-2,2'-dimethoxy-7,7'-dimethyl-3,3'-bis[(1e)-3-methylbut-1-en-1-yl]-9h,9'h-[9,9'-bianthracene]-10,10'-dione

4,4',5,5'-tetrahydroxy-2,2'-dimethoxy-7,7'-dimethyl-3,3'-bis[(1e)-3-methylbut-1-en-1-yl]-9h,9'h-[9,9'-bianthracene]-10,10'-dione

C42H42O8 (674.2879532000001)


   

7-[2-(1,5-dihydroxy-3-methoxy-10-methyl-9-oxoacridin-4-yl)ethenyl]-15-hydroxy-2,7,19,19-tetramethyl-5,8,18-trioxa-2-azapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁷,²²]docosa-1(22),3,9,11,14,16,20-heptaen-13-one

7-[2-(1,5-dihydroxy-3-methoxy-10-methyl-9-oxoacridin-4-yl)ethenyl]-15-hydroxy-2,7,19,19-tetramethyl-5,8,18-trioxa-2-azapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁷,²²]docosa-1(22),3,9,11,14,16,20-heptaen-13-one

C39H34N2O9 (674.2264194)


   

(1s,2s,4s,5r,6r,7s,9r,12r)-12-(acetyloxy)-6-[(acetyloxy)methyl]-7-(furan-3-carbonyloxy)-2-hydroxy-2,10,10-trimethyl-5-{[(2r)-2-methylbutanoyl]oxy}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-4-yl furan-3-carboxylate

(1s,2s,4s,5r,6r,7s,9r,12r)-12-(acetyloxy)-6-[(acetyloxy)methyl]-7-(furan-3-carbonyloxy)-2-hydroxy-2,10,10-trimethyl-5-{[(2r)-2-methylbutanoyl]oxy}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-4-yl furan-3-carboxylate

C34H42O14 (674.2574432)


   

7-[(1e)-2-(1,5-dihydroxy-3-methoxy-10-methyl-9-oxoacridin-4-yl)ethenyl]-15-hydroxy-2,7,19,19-tetramethyl-6,8,18-trioxa-2-azapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁷,²²]docosa-1(22),3,9,11,14,16,20-heptaen-13-one

7-[(1e)-2-(1,5-dihydroxy-3-methoxy-10-methyl-9-oxoacridin-4-yl)ethenyl]-15-hydroxy-2,7,19,19-tetramethyl-6,8,18-trioxa-2-azapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁷,²²]docosa-1(22),3,9,11,14,16,20-heptaen-13-one

C39H34N2O9 (674.2264194)


   

(3s,6r,10r,13e,16s)-10-[(3,5-dichloro-4-hydroxyphenyl)methyl]-9,12-dihydroxy-6-methyl-3-(2-methylpropyl)-16-[(1s)-1-[(2r,3r)-3-phenyloxiran-2-yl]ethyl]-1,4-dioxa-8,11-diazacyclohexadeca-8,11,13-triene-2,5-dione

(3s,6r,10r,13e,16s)-10-[(3,5-dichloro-4-hydroxyphenyl)methyl]-9,12-dihydroxy-6-methyl-3-(2-methylpropyl)-16-[(1s)-1-[(2r,3r)-3-phenyloxiran-2-yl]ethyl]-1,4-dioxa-8,11-diazacyclohexadeca-8,11,13-triene-2,5-dione

C34H40Cl2N2O8 (674.2161580000002)


   

6-[4-(acetyloxy)-5,9a-dimethyl-2,7-dioxo-tetrahydro-3h-pyrano[3,4-b]oxepin-5-yl]-5-(formyloxy)-3-(furan-3-yl)-7a-hydroxy-3a-methyl-7-methylidene-1-oxo-tetrahydro-2h-inden-4-yl 2-hydroxy-3-methylbutanoate

6-[4-(acetyloxy)-5,9a-dimethyl-2,7-dioxo-tetrahydro-3h-pyrano[3,4-b]oxepin-5-yl]-5-(formyloxy)-3-(furan-3-yl)-7a-hydroxy-3a-methyl-7-methylidene-1-oxo-tetrahydro-2h-inden-4-yl 2-hydroxy-3-methylbutanoate

C34H42O14 (674.2574432)


   

[2-(4-hydroxy-3-methoxyphenyl)-4-[(3-methoxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl]oxolan-3-yl]methyl 3,4,5-trihydroxybenzoate

[2-(4-hydroxy-3-methoxyphenyl)-4-[(3-methoxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl]oxolan-3-yl]methyl 3,4,5-trihydroxybenzoate

C33H38O15 (674.2210598)


   

(2s,3s,4r,4as,4br,7r,8ar,9r,10as)-3,9-bis(acetyloxy)-4-(benzoyloxy)-7-ethenyl-8a-hydroxy-1,1,4a,7-tetramethyl-5,8-dioxo-octahydrophenanthren-2-yl benzoate

(2s,3s,4r,4as,4br,7r,8ar,9r,10as)-3,9-bis(acetyloxy)-4-(benzoyloxy)-7-ethenyl-8a-hydroxy-1,1,4a,7-tetramethyl-5,8-dioxo-octahydrophenanthren-2-yl benzoate

C38H42O11 (674.2726982)